Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

NCT02285166 · clinicaltrials.gov ↗

COMPLETED

Status

15330

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Omega-3 fatty acid ethyl esters
DRUG: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).

Sponsor

Takeda